Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PERILOTO: Biomarkers in Cochlear Implantation
NCT05670158Recruiting
- Sponsor
- CHU Montpellier
- Start
- Dec 2023
- Primary completion
- Mar 2026
- Countries
- 1
01
Overview
Open-label trial (2 arms), sponsored by CHU Montpellier. Primary endpoints: Expression levels of proteins and metabolites in the perilymph at Day 0 and Expression levels of proteins and metabolites in the blood at Day 0. Started Dec 2023; status: recruiting.
Beyond the preview
Go deeper on NCT05670158.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05670158.